paragraph

On the back of the accelerated launch of innovative products, growing international footprint, and expanding customer base, domestic brokerage house BoB Capital Markets (BoB Caps) remains highly positive on the FMCG stock <a target="_blank" href="https://mintgenie.livemint.com/stocks/zydus-wellness-S0003672">Zydus Wellness</a>.

The brokerage has a 'buy' call on the stock with a target price of ₹2,185, indicating an upside of around 34 percent from its current market price of ₹1,636 (as on June 30). The brokerage said that the firm is in a sweet spot.

The stock has declined 22 percent in the last 1 year, however, it has recovered and added 15 percent from its 52-week low of ₹1,431, hit in February 2022.

"We retain buy on the back of new launches, increasing distribution strength, a broader presence through existing brands, its ability to cater to white spaces, and a strong gross margin which gives it the leeway to spend more on brand building. We are also positive on the firm’s debt reduction measures, faster free cash flow (FCF) generation and superior execution," BoB caps said in a recent note.The brokerage added that leading niche wellness brands (Sugar-Free, Everyuth, Glucon-D, Nycil) and low market penetration rates offer long-term growth opportunities to the stock. It also likes the company’s focus on distribution expansion and growth longevity with strong positioning.As per the brokerage, the average penetration level of the combined portfolio brands stands at 20 percent (12-24 percent across categories) signifies higher growth headroom versus its FMCG peers."Theoretically, increase in penetration is one of the growth planks for a category’s growth longevity. Further, management’s quest towards improving brand awareness (ad spends at 14 percent of revenue) and four-five new product/variants launches will not only improve penetration but also support double-digit growth in the foreseeable future," highlighted BoB Caps.Further, the brokerage is also bullish on the stock due to its strong outlook for international business. Its Sugar-Free and Complan brands constitute 93 percent of international business. The company has also entered new markets such as Hong Kong, Lebanon, Zimbabwe, Muscat, Ethiopia and Australia in FY22. Management has guided for high-double-digit growth in the international business, likely crossing ₹100 crore in revenue in FY23, noted BoB Caps.Zydus' target is to have 8-10 percent of revenue from the business in the next 4-5 years from 4 percent in FY22, it added.It also believes that restructuring of the distribution channel will continue to yield benefits as consumer sentiments improve and penetration levels rise across categories in which the company operates.Zydus Wellness is a unique play on India’s emerging health &amp; wellness category and enjoys market leadership in various niche segments with limited competition from large FMCG companies, said BoB Caps.Zydus Wellness is a consumer wellness company that operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands, such as Everyuth, Nutralite, Complan, Glucon-D, Sugarlite, Everyuth, Nycil and Sugar-Free D’lite.However, failure of new launches, aggressive competition from start-ups, inability to scale up acquired brands, rise in raw material prices, and economic slowdown/pandemic risk are key downside risks, noted the brokerage.Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of MintGenie.&nbsp;

Zydus Wellness in a sweet spot! BoB Caps sees the stock rising 34% going ahead

The brokerage has a 'buy' call on the stock with a target price of ₹2,185, indicating an upside of around 34 percent from its current market price of ₹1,636 (as on June 30).

Cryptocurrency prices today: Bitcoin, Ethereum rise marginally; most others trad

ITC shares hit 52-week high; up 30% this year; analysts see more upside

Reliance cracks 7% as govt imposes surprise duty on crude exports

Titan sheds 6% in intra-day deals as govt hikes gold import duty to strengthen falling rupee

Market Wrap: Sensex, Nifty end lower; RIL top drag

Five bullish candle patterns you should know

Realign the portfolio more towards the domestic-facing economy, says Manish Jeloka of Sanctum Wealth

Plunging Rupee Pushes India to Raise Taxes on Gold, Oil

Crypto Meltdown Claims Rolex and Patek Philippe as Victims

From Nithin Kamath of Zerodha to Uday Kotak: Market experts mourn Rakesh Jhunjhunwala's demise

The 62-year-old Rakesh Jhunjhunwala passed away on Sunday morning in Mumbai.

How does an investor measure a mutual fund’s volatility? Things you need to know

Before you invest in a mutual fund, you should evaluate its performance based on its returns as well as on the consistency of these returns — something that can be measured by standard deviation. We share more details on this here.

Zero cost term plans: Getting insurance premium back in case of discontinuance

Under these term insurance plans; policyholder can discontinue paying premiums at a stage of life where they feel they don’t need an insurance any more

Rakesh Jhunjhunwala: What made the man so special

<ul><li>Rakesh Jhunjhunwala has left a legacy behind. A perpetual believer of India story, he was always bullish about the country because of the immense opportunities. He had also been vocal about the reforms initiated by the government which he believed will not only facilitate India's growth at present, but will open several new opportunities in future also.</li></ul>

Rakesh Jhunjhunwala, India's Warren Buffet, dies at 62

A chartered accountant by profession from the desert state of Rajasthan, Jhunjhunwala started dabbling in stocks while in college and went on to manage a stock trading firm, RARE Enterprises.